[go: up one dir, main page]

DK0827537T3 - Chromatin-regulator-gener - Google Patents

Chromatin-regulator-gener

Info

Publication number
DK0827537T3
DK0827537T3 DK96914165T DK96914165T DK0827537T3 DK 0827537 T3 DK0827537 T3 DK 0827537T3 DK 96914165 T DK96914165 T DK 96914165T DK 96914165 T DK96914165 T DK 96914165T DK 0827537 T3 DK0827537 T3 DK 0827537T3
Authority
DK
Denmark
Prior art keywords
regulator genes
chromatin regulator
genes
chromatin
deregulation
Prior art date
Application number
DK96914165T
Other languages
Danish (da)
English (en)
Inventor
Thomas Jenuwein
Goetz Laible
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0827537T3 publication Critical patent/DK0827537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96914165T 1995-05-10 1996-05-02 Chromatin-regulator-gener DK0827537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19516776A DE19516776A1 (de) 1995-05-10 1995-05-10 Chromatin-Regulatorgene
PCT/EP1996/001818 WO1996035784A2 (fr) 1995-05-10 1996-05-02 Genes de regulation de la chromatine

Publications (1)

Publication Number Publication Date
DK0827537T3 true DK0827537T3 (da) 2008-12-01

Family

ID=7761318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96914165T DK0827537T3 (da) 1995-05-10 1996-05-02 Chromatin-regulator-gener

Country Status (11)

Country Link
US (2) US6689583B1 (fr)
EP (1) EP0827537B1 (fr)
JP (1) JP4295824B2 (fr)
AT (1) ATE404667T1 (fr)
CA (1) CA2220442C (fr)
DE (2) DE19516776A1 (fr)
DK (1) DK0827537T3 (fr)
ES (1) ES2313726T3 (fr)
MX (1) MX9708401A (fr)
PT (1) PT827537E (fr)
WO (1) WO1996035784A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6239327B1 (en) 1998-04-16 2001-05-29 Cold Spring Harbor Laboratory Seed specific polycomb group gene and methods of use for same
EP2133426A3 (fr) 1999-03-11 2010-04-14 Arborgen, Llc Compositions et procédés convenant à la modification de la transcription de gènes
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020155460A1 (en) * 2000-10-10 2002-10-24 Genencor International Inc. Information rich libraries
US7264964B2 (en) 2001-06-22 2007-09-04 Ceres, Inc. Chimeric histone acetyltransferase polypeptides
US20040053848A1 (en) * 2001-08-23 2004-03-18 Allis C. David Antibodies specific for methylated lysines in histones
EP1459754A4 (fr) * 2001-12-27 2005-08-31 Takeda Pharmaceutical Medicaments pour la prevention et le traitement du cancer
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
EP1577387A4 (fr) * 2002-12-24 2006-02-15 Takeda Pharmaceutical Medicaments preventifs/remedes pour le cancer
KR20060123413A (ko) * 2003-12-03 2006-12-01 추가이 세이야쿠 가부시키가이샤 포유류 β 액틴 프로모터를 이용한 발현계
JP2005170799A (ja) * 2003-12-08 2005-06-30 Univ Kurume ｚｅｓｔｅホモログ２のエンハンサーのＨＬＡ−Ａ２４結合ペプチド
ATE449168T1 (de) * 2004-06-01 2009-12-15 Univ North Carolina Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür
CN101389761A (zh) * 2006-02-27 2009-03-18 银怎株式会社 使用bmi-1使星形胶质细胞去分化成为神经干细胞
US8574832B2 (en) * 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
US20130195843A1 (en) * 2010-06-23 2013-08-01 British Columbia Cancer Agency Branch Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
US20130102477A1 (en) 2010-06-23 2013-04-25 Ryan D. Morin Biomarkers for non-hodgkin lymphomas and uses thereof
DK2614369T3 (en) 2010-09-10 2016-05-02 Epizyme Inc METHOD FOR DETERMINING THE SUITABILITY OF HUMAN EZH2 INHIBITORS TREATED
US9175331B2 (en) * 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
WO2012050963A2 (fr) 2010-09-29 2012-04-19 The General Hospital Corporation D/B/A Massachusetts General Hospital Agents fournissant des témoins et des étalons pour des tests d'immunoprécipitation
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
IL282732B2 (en) 2012-04-13 2023-04-01 Eisai R&D Man Co Ltd Salt form of human histone methyltransferase inhibitor 2ezh
JP6461803B2 (ja) 2012-10-15 2019-01-30 エピザイム，インコーポレイティド 置換ベンゼン化合物
WO2014153030A2 (fr) 2013-03-14 2014-09-25 Genentech, Inc. Méthodes de traitement du cancer et de prévention d'une résistance à un médicament anticancéreux
CN103215352B (zh) * 2013-03-29 2015-03-11 中国医学科学院血液病医院（血液学研究所） 一种检测setd2基因突变的试剂盒
SG11201602269QA (en) 2013-10-16 2016-04-28 Epizyme Inc Hydrochloride salt form for ezh2 inhibition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486623A (en) 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
EP0956032A4 (fr) 1996-12-20 2002-09-04 Univ Texas Proteines et compositions permettant de moduler la mitose
US6004933A (en) 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
US5972608A (en) 1997-08-27 1999-10-26 University Of Massachusetts Assays and reagents for chromatin remodeling enzymes and their modulators
EP1029547A1 (fr) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Composés pharmaceutiques actifs et procedé pour les identifiér
US6555329B2 (en) 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
EP1227160A1 (fr) 2001-01-19 2002-07-31 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Des composés qui influent la séparation des chromatides soeurs ainsi qu'une méthode pour les identifier
US20020164620A1 (en) 2001-01-19 2002-11-07 Boehringer Ingelheim International Gmbh Method for identifying compounds modulating sister chromatid separation
CA2445205A1 (fr) 2001-05-04 2003-03-27 University Of Florida Research Foundation, Inc. Clonage et sequencage de genes de pyruvate decarboxylase (pdc) provenant de bacteries et utilisations correspondantes

Also Published As

Publication number Publication date
WO1996035784A3 (fr) 1996-12-27
US7252968B2 (en) 2007-08-07
DE59611481D1 (en) 2008-09-25
JP4295824B2 (ja) 2009-07-15
PT827537E (pt) 2008-10-09
MX9708401A (es) 1998-02-28
EP0827537B1 (fr) 2008-08-13
WO1996035784A2 (fr) 1996-11-14
US20050089880A1 (en) 2005-04-28
CA2220442C (fr) 2011-07-12
CA2220442A1 (fr) 1996-11-14
EP0827537A2 (fr) 1998-03-11
ATE404667T1 (de) 2008-08-15
DE19516776A1 (de) 1996-11-14
US6689583B1 (en) 2004-02-10
ES2313726T3 (es) 2009-03-01
JP2001505402A (ja) 2001-04-24

Similar Documents

Publication Publication Date Title
DK0827537T3 (da) Chromatin-regulator-gener
ES2182906T3 (es) Grapa quirurgica helicoidal.
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
BR9805544C1 (pt) Uso de um composto.
TR199701056T1 (xx) Farnesil-protein transferaz enzimi inhibit�rleri.
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
MX9709146A (es) Compuestos novedosos, preparacion y uso de los mismos.
DE69635048D1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
PT815087E (pt) Derivados de fenilo trissubstituidos
DE69905170T2 (de) Thiazolopyrimidinderivate
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
TR199701074T1 (xx) Sinerjistik bile�imler.
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
HUP0104688A2 (hu) Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez
BR9912327A (pt) Inibidores da uroquinase
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ES2184861T3 (es) Compuestos peptidicos inhibidores de la liberacion de la metaloproteinasa y del tnf y su utilizacion terapeutica.
DK0876346T3 (da) Antimalariaaktive quinolinderivater
DE60037813D1 (de) Antworten auf hypoxia modifizieren
TR199802704T2 (xx) H�V tedavisinde Vx478, Zidov�din, FTC ve/veya 3TC i�eren kombinasyonlar�n kullan�m�.
ES2172682T3 (es) Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa.
ATE245163T1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
BG100248A (bg) Инхибитори на скваленсинтетаза